Orthofix Medical Inc.
Clinical trials sponsored by Orthofix Medical Inc., explained in plain language.
A medical device company focused on spinal and orthopedic products.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
-
Spine graft study abandoned after only 6 patients
Disease control Stopped earlyThis study aimed to compare a man-made bone graft material called Virtuos against using the patient's own bone for lumbar spine fusion surgery in people with degenerative disc disease. The goal was to see if Virtuos could achieve similar fusion rates at 12 and 24 months. However,…
Sponsor: Orthofix Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
Bone-Lengthening nail study ends early after just one patient
Knowledge-focused Stopped earlyThis study looked at the safety and performance of the Fitbone Transport and Lengthening Nail, a device implanted in the bone to help repair large bone gaps or correct leg length differences. Only one person took part before the study was stopped early, so the results are very li…
Sponsor: Orthofix Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:03 UTC